免费领取！《2025中国合成生物制造产业发展白皮书》

Core Viewpoint - The article emphasizes the rising importance of biomanufacturing as a strategic and innovative sector, which is seen as a new growth point that can drive industrial structure optimization and economic model transformation. The release of the "2025 China Synthetic Biomanufacturing Industry Development White Paper" highlights the current state and trends of biomanufacturing, analyzes the industry chain and key application directions, and provides insights into challenges and policy recommendations for the industry [1]. Group 1: Current State and Trends - The white paper outlines the development status and trends of biomanufacturing, including a comparative analysis of the biomanufacturing sectors in China and the United States [5]. - It discusses the key platform facilities in the global biomanufacturing industry, indicating the infrastructure necessary for growth [5]. - Future development trends in biomanufacturing are explored, suggesting potential directions for innovation and investment [5]. Group 2: Policy Landscape - The report details major policies affecting biomanufacturing both domestically and internationally, providing a comprehensive overview of regulatory environments [5]. - It categorizes foreign and domestic policies that impact the biomanufacturing industry, highlighting the importance of supportive regulations for growth [5]. Group 3: Industry Chain and Applications - An analysis of the biomanufacturing industry chain is presented, identifying key components and stakeholders involved in the sector [5]. - The report outlines several key application areas for biomanufacturing, including pharmaceuticals, food, personal care, agriculture, chemicals, materials, and energy, indicating the versatility of biomanufacturing technologies [5]. Group 4: Key Enterprises and Investment Landscape - The white paper identifies ten leading enterprises in China's biomanufacturing industry, showcasing significant players that are driving innovation and market growth [6]. - It also summarizes the strategic directions of 15 listed companies in synthetic biology, providing insights into their investment and development strategies [6]. - The investment and financing situation in the domestic synthetic biology sector for the period of 2024-2025 is discussed, indicating trends in capital flow and investment opportunities [6]. Group 5: Challenges and Recommendations - The report addresses the challenges faced by China's biomanufacturing industry, including technological, regulatory, and market-related issues that could hinder growth [6]. - Targeted policy recommendations are provided to address these challenges, aiming to foster a more conducive environment for the development of the biomanufacturing sector [6].